Document is current

Any future updates will be listed below

Vistusertib improves pulmonary inflammation and fibrosis by modulating inflammatory/oxidative stress mediators via suppressing the mTOR signalling

Crossref DOI link: https://doi.org/10.1007/s00011-024-01894-5

Published Online: 2024-05-24

Published Print: 2024-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark